Skip to content

Suicide in Urban Natives: Detection and Networks to Combat Events

Collaborative Hub to Reduce the Burden of Suicide Among Urban American Indian and Alaska Native Young Adults

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03136094
Acronym
SUNDANCE
Enrollment
698
Registered
2017-05-02
Start date
2020-03-15
Completion date
2025-05-31
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide Prevention

Keywords

American Indian, Alaska Native, Youth and Young Adult, SBIRT

Brief summary

This study compares the effectiveness of a program to detect and manage suicide risk among American-Indian and Alaska Native (AI/AN) youth. Half of the participants will receive caring text messages to reduce suicidal thoughts, attempts, and hospitalizations and to increase engagement, social connectedness, and resilience in at-risk youth. The other half will receive usual care that does not include the caring text messages.

Detailed description

The study, Suicide in Urban Natives: Detection and Networks to Combat Events, builds on Screening, Brief Intervention and Referral to treatment (SBIRT), carried out through the primary care setting, to detect and manage suicide risk. This approach is multilevel, targeting both the healthcare system and the individual, and links screening to existing mobile phone technologies shown to promote resilience and to tap the protective benefits of social connectedness. This Collaborative Hub will conduct a randomized control trial that compares the effectiveness of enhancing these SBIRT programs by sending caring text messages to reduce suicidal ideation, attempts, and hospitalizations, and to increase engagement, social connectedness, and resilience. The Investigators' long-term goal is to disseminate and translate the lessons learned into practical policy, organizational changes, and preventive innovations that optimize patient-centered health outcomes and ultimately reduce or eliminate the dramatic and tragic suicide-related health disparities among urban AI/AN youth and young adults.

Interventions

BEHAVIORALSBIRT+12

The standard SBIRT model is augmented by a 12 month period following identification of suicide risk during which participants received caring text messages adapted from empirically-based, effective interventions for suicide prevention among American Indian and Alaska Native young adults.

BEHAVIORALSBIRT+Usual Care

Patients receive usual SBIRT care

Sponsors

Washington State University
CollaboratorOTHER
University of New Mexico
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Patients will not be given details about how text messaging differs for the 2 study groups. Instead, patients will be told that the clinic is testing a program to support people who are having hard times, and that they will receive periodic text messages from the Site Coordinator for the next 12 months.

Intervention model description

The Investigators will conduct a randomized controlled trial to test the effectiveness of an augmented Screening, Brief Intervention, and Referral to Treatment (SBIRT) model that includes sending caring text messages for 12 months after an at-risk patient is identified.

Eligibility

Sex/Gender
ALL
Age
18 Years to 34 Years
Healthy volunteers
No

Inclusion criteria

* Self-identify as American Indian or Alaska Native; * Screen positive for mild, moderate, or severe risk of suicidality (referred by a clinical provider); * Have a text-enabled mobile phone; * Willing to be contacted by text; * Able to participate voluntarily; * Speak and read English; * Cognitively able to independently provide written informed consent

Exclusion criteria

* Under age 18 * In danger of imminent self-harm; * Hospitalized

Design outcomes

Primary

MeasureTime frameDescription
Change in Suicidal IdeationBaseline, 6 months, 12 monthsThe 15-item Suicidal Ideation Questionnaire Jr. assesses frequency of suicidal thoughts in the past month. Item content ranges from general thoughts of death and wishes that one were dead to specific thoughts of self-injurious behavior. Responses are on a 7-point scale ranging from never to almost daily. Items are summed for a total score (range 0-90).
Change in Self-Reported Suicide AttemptsBaseline, 6 months, 12 monthsThe investigators will use the interviewer-administered Suicide Attempt and Self-Injury Count to assess the method, intent, treatment received, and lethality for all suicide attempts over the respondent's lifetime.
Change in Hospitalizations and Behavioral Health TreatmentBaseline, 6 months, 12 monthsThe investigators will assess self-reported hospitalizations over the previous 12 months with a measure of health service use previously applied to AI/ANs. It captures information on inpatient and outpatient medical care, emergency room visits, and use of traditional practices.

Secondary

MeasureTime frameDescription
Change in Social ConnectednessBaseline, 6 months, 12 monthsThe investigators will assess social connectedness with the Interpersonal Needs Questionnaire, a validated measure of feelings of connectedness to others and of being a burden on others.
SBIRT Retention and Uptake of Referral to Therapy6 months, 12 monthsRetention will be measured as binary indicators of complete participation in the appropriate level of intervention determined during the initial in-person session with the behavioral therapist before enrollment in the study, and as uptake of therapy services for people who are referred to this level of care. For each participant, we will create a 3-category indicator of retention (full, partial, none).

Countries

United States

Contacts

Primary ContactErin Poole, MS
erin.poole@CUAnschutz.edu(303) 724-0177

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026